


下載本文檔
版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、58例鼻咽癌患者放射性核素骨顯像分析摘要目的:探討鼻咽癌、期初診患者骨顯像的診斷價(jià)值。方法:58例未經(jīng)放療、化療的鼻咽癌、期初診患者,均分別行核素骨顯像、骨x線(xiàn)平片、骨ct檢查。核素骨顯像于靜脈注射99mtc-mdp36h后進(jìn)行。結(jié)果:58例鼻咽癌、期初診患者中有13例最后經(jīng)臨床確診為鼻咽癌骨轉(zhuǎn)移。骨顯像診斷骨轉(zhuǎn)移的靈敏度為84.6,特異性為82.2,假陽(yáng)性率為17.7,假陰性率15.4。病灶主要集中于脊椎、肋骨和骨盆。骨顯像與x線(xiàn)、ct檢查對(duì)轉(zhuǎn)移灶診斷的靈敏度分別為84.6、61.5和69.2,核素骨顯像靈敏度明顯高于x線(xiàn)平片和ct(p0.05)。本組病例中,患者有疼痛主訴者骨顯像的陽(yáng)性率高
2、;n分期晚者其陽(yáng)性率也高。結(jié)論:全身骨顯像在診斷鼻咽癌、期初診患者有無(wú)骨轉(zhuǎn)移中有重要的臨床價(jià)值,其靈敏度高于x線(xiàn)平片和ct檢查;骨顯像陽(yáng)性率的高低與疼痛主訴及n分期密切相關(guān),在病例篩選中可作為首選檢查項(xiàng)目。鼻咽癌多屬低分化鱗狀細(xì)胞癌,遠(yuǎn)處轉(zhuǎn)移發(fā)生率高,在死亡患者中,半數(shù)或半數(shù)以上有骨、肝、肺等處轉(zhuǎn)移13。放射性核素骨顯像有早期發(fā)現(xiàn)骨轉(zhuǎn)移灶的特點(diǎn),已被臨床高度重視46?,F(xiàn)就我院1996年1月至1997年10月收治的58例鼻咽癌初診患者的骨顯像結(jié)果分析如下。1方法1病例來(lái)源58例未經(jīng)放療、化療的鼻咽癌初診患者,全部經(jīng)病理證實(shí)為鼻咽部低分化鱗狀細(xì)胞癌。其中男性42例,女性16例。年齡最大69歲,最小
3、31歲,中位年齡49.6歲。臨床分期(按1992年福州分期標(biāo)準(zhǔn))iii期35例,iva16例,ivb7例。全部患者均隨訪(fǎng)至今。所有患者均行骨顯像、x線(xiàn)和ct檢查,骨顯像、x線(xiàn)平片及ct檢查之間時(shí)間間隔不超過(guò)3d。臨床骨轉(zhuǎn)移的確診依據(jù):臨床隨訪(fǎng)、部分病變行針吸活檢。2方法核素用锝-99m二甲基磷酸鹽(99mtc-mdp)740925mbq,靜脈注射后36h行全身顯像;ect為日本toshibagca-901a/sa型,配低能高分辨準(zhǔn)直器。2.1采集條件矩陣256512,探頭走速1525cm,能峰140kev,窗寬20;前后位和后前位各采集1幅,采集前病人排空小便。2.2骨顯像陽(yáng)性判斷標(biāo)準(zhǔn)與健側(cè)或
4、相鄰正常組織相對(duì)比,病變部位出現(xiàn)放射性分布增高或減低為陽(yáng)性,增高者定義為濃聚灶;減低者定義為減低灶。2結(jié)果58例鼻咽癌、期初診患者中經(jīng)臨床確診為骨轉(zhuǎn)移的有13例。骨顯像為陽(yáng)性的有19例,在此19陽(yáng)性病例人,出現(xiàn)全身多發(fā)性病灶(包括濃聚灶和減低灶)的有13例,出現(xiàn)單發(fā)性病灶的有6例;骨顯像共檢出病灶總數(shù)為72個(gè),病灶在頭顱有6個(gè)/6例、肋骨36個(gè)/8例、胸骨9個(gè)/6例,脊柱13個(gè)/8例、骨盆5個(gè)/3例,四肢3個(gè)/2例。骨顯像的診斷結(jié)果見(jiàn)表1。表158例鼻咽癌患者骨顯像結(jié)果tab.1theradionuclideboneimagingresultsof58patientswithcorstagee
5、ctclinicaldiagnositotalwithbonemetastasiwithoutbonemetastasipositive11819negative23739total134558由決策矩陣分析可知,骨顯像對(duì)骨轉(zhuǎn)移的診斷靈敏度為84.6,特異性為82.2,假陽(yáng)性率為17.7,假陰性率為15.4。在限定部位,骨顯像與x線(xiàn)平片、ct比較,靈敏度分別為84.6(11/13)、61.5(8/13)、69.2(9/13)。經(jīng)統(tǒng)計(jì)學(xué)處理,骨顯像高于其它二者(p0.05)。骨顯像與患者疼痛的關(guān)系:頭痛6/8例、腰痛6/6例、胸痛3/4例、關(guān)節(jié)痛2/2例骨顯像陽(yáng)性。58例患者中,n分期為n2者5
6、/7例、n3者6/6例骨顯像陽(yáng)性,臨床皆證實(shí)為骨轉(zhuǎn)移。n分期為n0和n1者皆未見(jiàn)骨轉(zhuǎn)移,骨顯像也皆為陰性。3討論鼻咽癌晚期患者常出現(xiàn)全身骨轉(zhuǎn)移。轉(zhuǎn)移途徑大多數(shù)首先經(jīng)淋巴結(jié)轉(zhuǎn)移,隨后進(jìn)入循環(huán)系統(tǒng)而向全身骨轉(zhuǎn)移;少數(shù)也可直接侵及椎靜脈,而向全身骨髂播散。受累骨髂以脊椎、肋骨和骨盆多見(jiàn)13。本組結(jié)果中,經(jīng)臨床最后確診同時(shí)骨顯像也陽(yáng)性的11例病人中,其骨髂病損部位也主要集中于以上部位。從骨顯像診斷結(jié)果看,其靈敏度和特異性都有較高,分別為84.6和82.2,與文獻(xiàn)報(bào)導(dǎo)相似46。與x線(xiàn)和ct相比,骨顯像能進(jìn)行全身掃描,便于發(fā)現(xiàn)全身骨病灶;在限定部位,其對(duì)轉(zhuǎn)移灶早期診斷靈敏度和準(zhǔn)確率也都明顯高于x線(xiàn)平片和c
7、t。所以,為了了解鼻咽癌晚期患者有無(wú)骨轉(zhuǎn)移,骨顯像可做為過(guò)篩首選。疼痛與骨顯像陽(yáng)性率之間有一定關(guān)系。鼻咽癌骨、關(guān)節(jié)轉(zhuǎn)移常出現(xiàn)局部疼痛和壓痛,部位較恒定。出現(xiàn)骨疼的病人其骨病變一般都較明顯,這些病人骨顯像多為陽(yáng)性,但是否轉(zhuǎn)移則與疼痛部位有關(guān),在本組病例中,出現(xiàn)腰痛、胸痛、四肢關(guān)節(jié)痛的11例患者中,骨顯像皆出現(xiàn)一處或多處濃聚灶,經(jīng)臨床觀(guān)察為骨轉(zhuǎn)移;但在8例頭痛患者中,雖骨顯像結(jié)果6例出現(xiàn)顴骨、額骨濃聚灶,但經(jīng)臨床觀(guān)察此6例患者都不屬于骨轉(zhuǎn)移。因此,一旦鼻咽癌iii、iv期患者主訴腰痛、胸痛、四肢關(guān)節(jié)痛,要重視發(fā)生骨轉(zhuǎn)移的可能性。在n分期中n2分期5/7例、n3分期6/6例骨顯像陽(yáng)性,最后臨床都證實(shí)
8、為骨轉(zhuǎn)移,而n分期為n1和n0者,皆未發(fā)現(xiàn)有骨轉(zhuǎn)移,骨顯像也皆為陰性。說(shuō)明n分期與骨轉(zhuǎn)移密切相關(guān),這可能是由于鼻咽癌首先出現(xiàn)淋巴結(jié)轉(zhuǎn)移,隨后出現(xiàn)多發(fā)性骨轉(zhuǎn)移有關(guān)。所以,對(duì)n分期晚者骨顯像最好做為常規(guī)檢查項(xiàng)目。核素骨顯像存在一定的假陽(yáng)性和假陰性,本組病例中,骨顯像的假陽(yáng)性率和假陰性分別為17.7和15.4。我們知道骨轉(zhuǎn)移多為多發(fā)性,骨顯像表現(xiàn)為多發(fā)性濃聚灶或多發(fā)性減低灶者,其特異性很高。但表現(xiàn)為單發(fā)灶,特別是點(diǎn)狀濃聚灶者,可以是炎癥、外傷、痛風(fēng)等引起,則特異性較低,在本文假陽(yáng)性的8例患者中,多數(shù)為頭面骨及肋骨單發(fā)性濃聚灶,核醫(yī)學(xué)科亦常不作為“轉(zhuǎn)移灶”診斷。假陰性2例患者中1例為頸椎、1例為骶椎轉(zhuǎn)
9、移,此部位多受前位的甲狀腺及膀胱中尿液影響。因此,對(duì)于骨顯像受甲狀腺及膀胱影響較大難以診斷,而臨床又高度懷疑骨轉(zhuǎn)移者,要結(jié)合x(chóng)線(xiàn)平片、ct檢查進(jìn)行診斷(這2例患者經(jīng)ct、x線(xiàn)檢查證實(shí)為頸椎和骶骨轉(zhuǎn)移)。參考文獻(xiàn)1李振權(quán),潘啟超,陳劍經(jīng)等.鼻咽癌臨床與實(shí)驗(yàn)研究.廣東:廣東科技出版社,1983.1992022谷銑之,殷蔚伯,劉泰福等.腫瘤放射治療學(xué).北京:北京醫(yī)科大學(xué)、中國(guó)協(xié)和醫(yī)科大學(xué)聯(lián)合出版社,1993.4434443湯釗猷.現(xiàn)代腫瘤學(xué).上海:上海醫(yī)科大學(xué)出版社,1993.5865884林偉,石銳.放射性核素三相骨顯象對(duì)原發(fā)性骨腫瘤良惡性的鑒別診斷.中華核醫(yī)學(xué)雜志,1990,10:1935劉新義
10、,王平輝.鼻咽癌核素骨顯像的臨床價(jià)值.腫瘤研究與臨床,1994,6(1):206吳超權(quán),杜瑞生.112例鼻咽癌病人放療前核素骨掃描結(jié)果分析.中華放射腫瘤學(xué)雜志,1998,7(4):256p tgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgk tgz7r4i30ka1dkaghn3xtkknbycudxqa7fh
11、yi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2 tgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7x
12、av2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawger4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycud
13、xqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7
14、r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2 tgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtk
15、knbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawger4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa
16、3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2tgz7r4i30ka1dkagh
17、n3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawger4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tg
18、kqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauw
19、ydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2eo8wgqv7xav2ohum32wgeauwydiawger4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa
20、7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i
21、30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkaggeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycud
22、xqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawger4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r
23、4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav hhi92tgkqcwa3ptgz7r4i30k
24、a1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawger4i30ka1dk
25、aghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgz7r4i30ka1dkagtgkqcwa3ptgz7r4i30ka1dkaghn3xtkknbycudxqa7fhyi2chhi92tgkqcwa3ptgshls50clmtwn60eo8wgqv7xav2ohum32wgeauwydiawgmer4i30ka1dkaghn3xtkkn
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2020CXO行業(yè)分析研究報(bào)告
- 2025年賽力皮革染料項(xiàng)目合作計(jì)劃書(shū)
- 加盟粉店合同范本
- 合同范本修編
- 合同范本 驗(yàn)收標(biāo)準(zhǔn)
- 銀行保險(xiǎn)合同范本
- 雙孢菇銷(xiāo)售合同范本
- 2000施工合同范本
- 合伙資產(chǎn)轉(zhuǎn)讓合同范例
- 參團(tuán)合同范本
- 專(zhuān)題 勾股定理與全等三角形的綜合運(yùn)用( 基礎(chǔ)題&提升題&壓軸題 )(解析版)
- (高清版)TDT 1013-2013 土地整治項(xiàng)目驗(yàn)收規(guī)程
- 內(nèi)蒙古機(jī)電職業(yè)技術(shù)學(xué)院?jiǎn)为?dú)招生(機(jī)電類(lèi))專(zhuān)業(yè)知識(shí)考試題庫(kù)(必練500題)
- 電梯井道作業(yè)安全規(guī)程培訓(xùn)
- 人教版三年級(jí)上冊(cè)數(shù)學(xué)應(yīng)用題100題及答案
- 大數(shù)據(jù)在人力資源管理中的應(yīng)用案例
- 福州地鐵公司招聘考試題目
- 2024-2025年美的集團(tuán)財(cái)務(wù)報(bào)表分析
- 小學(xué)語(yǔ)文期末質(zhì)量分析報(bào)告
- 小學(xué)科學(xué)質(zhì)量分析報(bào)告
- 2023年大學(xué)日語(yǔ)四級(jí)考試試題答案
評(píng)論
0/150
提交評(píng)論